Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains

Physiological Genomics

Volumn 24, Issue 1, 2005, Pages 59-64

  Klöting, Nora ^a   Follak, Niels ^a   Klöting, Ingrid ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Congenic rats; Type 1 diabetes

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CALCINEURIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR YY1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BONE; CONTROLLED STUDY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; MALE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA TRANSCRIPTION; STATISTICAL SIGNIFICANCE; TIBIA;

ANIMALS; AUTOIMMUNITY; BLOOD GLUCOSE; BONE AND BONES; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; GENE EXPRESSION REGULATION; INSULIN; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED BB; REFERENCE VALUES; RNA; RNA, RIBOSOMAL, 18S;

ANIMALIA;

EID: 33645791260     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00094.2005     Document Type: Article

References (48)

1. Balaburski G and O'Connor JP. Determination of variations in gene expression during fracture healing. Acta Orthop Scand 74: 22-30, 2003.
2. Beam HA, Parsons JR, and Lin SS. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 20: 1210-1216, 2002.
3. Billingham RE and Silvers WK. Inbred animals and tissue transplantation immunity. Transplant Bull 6: 399-406, 1959.
4. Chen D, Zhao M, Harris SE, and Mi Z. Signal transduction and biological functions of bone morphometric proteins. Front Biosci 9: 349-358, 2004.
5. Chen HY, Chen WC, Wu MC, Tsai FJ, and Lin CC. Interleukin-1β and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Maturitas 30: 49-54, 2003.
6. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van der Bent C, Papapoulos SE, and Lowik CW. Bone morphogenic proteins stimulate angiogenesis through oeteoblast-derived vascular endothelial growth factor A. Endocrinology 143: 1543-1553, 2002.
7. Dick IM, Devine A, Li S, Dhaliwal SS, and Prince RL. The T869C TGFβ polymorphism is associated with fracture, bone mineral density, and calcaneal quantitative ultrasound in elderly women. Bone 33: 335-341, 2003.
8. Follak N, Klöting I, Ganzer D, and Merk H. Scanning electron microscopic examinations on retarded bone defect healing in spontaneously diabetic BB/O(ttawa)K(arlsburg) rats. Histol Histopathol 18: 111-120, 2003.
9. Follak N, Klöting I, Wolf W, and Merk H. Delayed remodelling in the early period of fracture healing in spontaneously diabetic BB/OK rats depending on the diabetic metabolic state. Histol Histopathol 19: 473-486, 2004.
10. Follak N, Klöting I, Wolf E, and Merk H. Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats. Bone 35: 144-152, 2004.
11. Funk JR, Hale JE, Carmines D, Gooch HL, and Hurwitz SR. Biomechanical evaluation of early fracture healing in normal and diabetic rats. J Orthop Res 18: 126-132, 2000.
12. Herskin A, Christensen K, Norgaard-Andersen K, and Andersen F. Diabetes mellitus and healing of closed fractures. Diabetes Metab 18: 63-64, 1992.
13. Hirotani H, Tuohy NA, Woo JT, Stern PH, and Clipstone NA. The calcineurin/nuclear factor of activated T cells signalling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 14: 13984-13992, 2004.
14. Klöting N, Follak N, and Klöting I. Diabetes per se and metabolic state influence gene expression in tissue-dependent manner of BB/OK rats. Diabetes Metab Res Rev 21: 281-287, 2005.
15. Klöting N, Wilke B, and Klöting I. Phenotypic and genetic analysis of subcongenic BB. SHR rat lines shorten the region on chromosome 4 bearing gene(s) for underlying facets of metabolic syndrome. Physiol Genomics 18: 325-330, 2004.
16. Klöting I, Kovacs P, and Kuttler B. Phenotypic consequences after restoration of lymphopenia in the diabetes-prone BB/OK rat. Biochem Biophys Res Commun 239: 106-110, 1997.
17. Klöting I, Kovacs P, and van den Brandt J. Congenic BB.SHR (D4Mit6-Npy-Spr) rats: a new aid to dissect the genetics of obesity. Obesity Res 10: 1074-1077, 2002.
18. Klöting I, Kovacs P, and van den Brandt J. Sex-specific and sex-independent quantitative trait loci for facets of the metabolic syndrome in WOKW rats. Biochem Biophys Res Commun 284: 150-156, 2001.
19. Klöting I, Voigt B, and Kovacs P. Metabolic features of newly established congenic diabetes-prone BB. SHR rat strains. Life Sci 62 :973-979, 1998.
20. Klöting I, Voigt B, and Vogt L. Molecular analysis of diabetes-prone BB rat sublines and derivatives of their common ancestor as a tool to search for candidate loci causing different phenotypes in BB rats. Diabetes Res 29: 65-71, 1995.
21. Klöting I and Vogt L. BB/O(ttawa)K (arlsburg) rats: features of a subline of diabetes-prone BB rats. Diabetes Res 18: 79-87, 1991.
22. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, and Einhorn TA. Expression of osteoprotegrin, receptor activator of NF-κB ligand (osteoprotegrin ligan) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 1004-1014, 2001.
23. Krakauer J, McKenna M, Burderer N, Rao D, Whitehouse F, and Pafitt A. Bone loss and bone turnover in diabetes. Diabetes 44: 775-782, 1995.
24. Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten DP, Heldin CH et al. Nuclear factor YY1 inhibits transforming growth factor b and bone morphogenic protein-induced cell differentiation. Mol Cell Biol 23: 4494-4510, 2003.
25. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, and Fortun Y. IL-6, RANKL, TNF-α/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15: 49-60, 2004.
26. Levin M, Boisseau V, and Avioly L. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 294: 241-245, 1976.
27. Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, and Quattrin TJ. Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 26: 2365-2369, 2003.
28. Lopez-Ibarra PJ, Pastor MM, Escob-Jimenez F, Pardo MD, Gonzalez AG, Luna JD, Requena ME, and Diosdado MA. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract 7: 346-351, 2001.
29. Lu H, Kraut D, Gerstenfeld LC, and Graves TD. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology 144: 346-352, 2003.
30. Macey LR, Kana SM, Jingushi S, Terek RM, Borretos J, and Bolander ME. Defects of early fracture healing in experimental diabetes. J Bone Joint Surg Am 71: 722-733, 1989.
31. Mishima N, Sahara N, Shirakawa M, and Ozawa H. Effect of streptozotocin-induced diabetes mellitus on alveolar bone deposition in the rat. Arch Oral Biol 47: 843-849, 2002.
32. Munoz-Torres M, Jodar E, Escobar-Jimenenz F, Lopez-Ibarra P, and Luna J. Bone mineral density measured by dual x-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int 58: 316-319, 1996.
33. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, and Huard J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110: 751-759, 2002.
34. Rabinovich A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Res Rev 14: 129-151, 1998.
35. Rho J, Takami M, and Choi Y. Osteoimmunology: interactions of the immune and skeletal systems. Mol Cells 17: 1-9, 2004.
36. Rundle CH, Miyakoshi N, Ramirez E, Wergedal JE, Lau KH, and Baylink DJ. Expression of the fibroblast growth factor receptor genes in fracture repair. Clin Orthop 403: 253-263, 2002.
37. Shore RM, Chesney RW, Mazess RB, Rose PR, and Bargman GJ. Osteopenia in juvenile diabetes. Calif Tissue Int 33: 455-457, 1981.
38. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, and Filvaroff EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 9656-9661, 2002.
39. Szczesny G. Molecular aspects of bone healing and remodelling. Pol J Pathol 538: 145-153, 2002.
40. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 53: 170-179, 2005.
41. Tashiro M, Samuelson LC, Liddle RA, and Williams JA. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice. Am J Physiol Gastrointest Liver Physiol 286: G784-G790, 2004.
42. Topping R, Bolander M, and Balian G. Type X collagen in fracture callus and the effects of experimental diabetes. Clin Orthop 308: 220-228, 1994.
43. Tyndall WA, Beam HA, Zarro C, O'Connor JP, and Lin SS. Decreased platelet-derived growth factor expression during fracture healing in diabetic animals. Clin Orthop 408: 319-330, 2003.
44. u haplotype) rat. Metabolism 49: 1140-1144, 2000.
45. Verhaeghe J, Suiker AM, Einhorn TA, Geusens P, Visser WJ, Van Herck E, Van Bree R, Magitsky S, and Bouillon R. Brittle bone in spontaneously diabetic female rats cannot be predicted by bone mineral measurements studies in diabetic and ovarectomised rats. J Bone Miner Res 9: 1657-1667, 1994.
46. Verhaeghe J, Suiker AM, Nyomba BL, Visser WJ, Einhorn TA, Dequeker J, and Bouillon R. Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 124: 573-582, 1989.
47. Verhaeghe J, Suiker AM, Visser WJ, Van Herck E, Van Bree R, and Bouillon R. The effects of systemic insulin, insulin-like growth factor-1 and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol 134: 485-492, 1992.
48. Verhaeghe J, Van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, and Bouillon R. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 139: 477-482, 1990.